Public COA audit
Triple Agonist
Audited July 28, 2026
Several fields check out, but we found issues worth reviewing before you rely on this document.
- Legitimacy
- 92
- Confidence
- 88%
- Panels
- 3/7
- Purity (printed)
- 99.8%
Document details
Fields extracted from the certificate — not order or payment data.
- Batch / lot
- CR-3XAG10-2603-1
- Identity method
- FTIR (USP <197A>) and HPLC (USP <621>)
- Sample date
- 2026-04-02
- Issue date
- 2026-04-05
7-panel checklist
Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.
3 of 7 present · 3 passed · 0 failed · 0 reported · 4 missing
Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.
Identity
Tested · passed · core
Compound identity confirmed (e.g. HPLC, mass spec).
FTIR sample spectrum confirms the presence of Triple Agonist with addition of excipient(s)/fillers
Purity
Tested · passed · core
Reported purity percentage for the analyte.
99.8%
Heavy metals
Not on this COA
Lead, arsenic, cadmium, mercury, or similar limits.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Microbial
Not on this COA
Bioburden / microbial limits testing.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Endotoxin
Tested · passed · core
LAL or chromogenic endotoxin assay.
18.0 EU/vial (limit: 40 EU/vial)
Sterility
Not on this COA
Sterility testing where applicable.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Residual solvent / water
Not on this COA
Residual solvents or water content limits.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
How to read this
Had data · good
Panel present with a pass (or clear acceptance).
Had data · bad
Panel present with a fail — a concrete quality signal.
Had data · unclear
Value reported without an explicit pass/fail mark.
Missing
Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.
Findings
Evidence-linked observations from this audit.
High HPLC purity achieved
99.8% purity meets specification of ≥98%, which is normal for research-grade peptides
Identity confirmed by FTIR and HPLC
FTIR spectrum confirms Triple Agonist presence with excipients; HPLC chromatogram shows single dominant peak at 9.933 min retention time
Batch/lot number clearly stated
CR-3XAG10-2603-1
Testing and issue dates present and logical
Sample tested 4/2/2026, COA issued 4/5/2026, endotoxin test dated 4/8-4/10/2026 - all dates are sequential and on or before 2026-07-28
Testing lab identified with contact information
BTLabs, West Palm Beach FL, with phone, email, and website provided
Endotoxin testing included
Separate endotoxin COA (page 3) shows 18.0 EU/vial result, passing 40 EU/vial limit
Heavy metals testing not performed
No heavy metals panel present; common omission for research peptides but worth noting
Microbial/sterility testing not performed
Testing purpose explicitly states it does not provide information on microbial contamination
Professional multi-page format with chromatograms
Includes FTIR spectrum, HPLC chromatogram, potency assay data across three pages with consistent branding and QR codes
PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.